NEW YORK (GenomeWeb) – In a filing with the US Securities and Exchange Commission today, Agilent Technologies announced it is planning an offering of a series of senior notes.
In a document filed today as a supplement to a prospectus dated Feb. 12, the company said the notes would be due in 2026, and issued in minimum denominations of $2,000 and at increments of $1,000 beyond that. Other details, including aggregate principal, interest rate, and maturity were not disclosed and will depend on market conditions at the time of pricing, Agilent said in a statement.
The firm added that it intends to use the proceeds to repay "all amounts outstanding under its revolving credit facility and for general corporate purposes."
BNP Paribas, Citigroup, and Credit Suisse will act as joint book-running managers. Barclays, HSBC, Lloyds Securities, and Wells Fargo Securities will act as co-managers.
According to Agilent's Form 10-Q filed Sept. 7, the company had borrowings of $235 million outstanding under a five-year revolving credit facility as of July 31, expiring in September 2019. As reported by GenomeWeb, in July 2015, the firm increased the credit facility to $700 million from $400 million.
Agilent's shares rose more than 1 percent to $45.47 in afternoon trading on the New York Stock Exchange.